Is National Organization For Rare Disorders Inc Legit?

The National Organization For Rare Disorders Inc (NORD) demonstrates strong financial health and growth over the past decade. Revenue has significantly increased from $20.4 million in 2015 to $66.3 million in 2023, with assets growing from $13.7 million to $65.1 million in the same period. The organization consistently maintains a healthy surplus, with revenues generally exceeding expenses, indicating sound financial management and sustainability. For instance, in 2023, NORD reported revenues of $66,397,453 against expenses of $52,832,739, resulting in a substantial surplus. NORD's spending efficiency appears robust, as evidenced by its consistent ability to generate surpluses and grow its asset base. While specific program, administrative, and fundraising spending ratios are not provided in the raw data, the overall financial picture suggests effective resource allocation. The absence of reported officer compensation in the provided data for all periods is a notable point regarding transparency, suggesting either that compensation is not reported in this specific field or that it is exceptionally low, which would be a positive indicator for donor confidence. Overall, NORD exhibits characteristics of a well-managed and financially stable nonprofit. Its consistent growth in revenue and assets, coupled with a healthy financial surplus in most years, points to a strong capacity to fulfill its mission. The lack of reported officer compensation in the provided data, if accurate, further enhances its transparency profile.